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Abstract
This project investigates the optimisation of the detector packing required for the
electromagnetic screening of the in vivo urethral mini-dosimeter, developed by the
Centre for Medical Radiation Physics (CMRP), through Monte Carlo simulations.
Monte Carlo simulations were performed for the device detector within a liquid
water phantom to optimise the geometry of the device encapsulation, with a priority
on angular isotropy and depth-dose response.
Monte Carlo simulations were performed to determine the effect of the depletion
region depth on angular isotropy and depth dose response of the detector. The use
of a thin, grounded, aluminium shield within the device encapsulation was found to
not substantially perturb the response of the detector within the device. The
normalised depth-dose response of the device was within ±2.0% of the simulated
doses in water, up to 35mm and within ±5.3% of the simulated doses in water, up to
50mm from a brachytherapy seed, for all thicknesses of aluminium shielding. The
angular isotropy response distribution was within ±3.8% for 20µm of aluminium
shielding, ±3.0% for 50µm of aluminium shielding and ±2.5% for 100µm of aluminium
shielding. The depletion depth was found to have an effect on the angular isotropy
and depth dose response of the device, necessitating full depletion for optimal
operation. The urethral mini dosimetry system will provide real time monitoring of
the urethral dose during low dose rate

prostate

additional quality assurance of the treatment modality.

brachytherapy,

allowing
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1. Introduction
Prostate cancer is the most common type of cancer in Australian men and the second
most common cause of cancer related deaths in men. It is estimated that
approximately 20,000 new cases of prostate cancer are diagnosed every year in
Australia with almost 3,300 deaths annually [1].
Prostate cancer is curable if detected and treated early, whilst the cancer is confined
to the prostate gland [1]. Prostate cancer can be detected via a blood test that detects
the amount of prostate specific antigen (PSA), a protein produced by the prostate cell,
in the blood or by a digital rectal examination (DRE), in which a doctor feels for
abnormalities on the surface of the prostate [1]. Low dose rate brachytherapy, through
real time transrectal ultrasound guided transperineal placement of permanent iodine125 or Pallidium-103 seeds, is a common treatment modality for early stage prostate
cancer [2].
The Centre for Medical Radiation Physics (CMRP), University of Wollongong
(UOW),

has developed a new quality assurance system, designed to measure

accurately the dose along the urethra during low dose rate prostate brachytherapy
with iodine-125 seeds. This system has been validated to be operational in vivo at body
temperature with a near isotropic response to radiation with angles. The system has
been designed to complement ultrasound guided seed placement by providing online
direct dosimetry within the urethra during seed implantation, as well as providing
dose planning system verification through post implant dosimetry.
1

The system developed by the CMRP is based on mini-silicon detector probe, which
has an active volume less than 1 mm3, and is encapsulated in a polyamide film
(kapton). A Field Effect Transistor (FET) is directly coupled to the detector to provide
immediate amplification of the pulse with minimal loss of signal. The system has been
designed to be small and flexible enough to be placed into a Foley catheter which
is inside the urethra during implantation. The probe connects to a data acquisition
unit which displays in real time the urethral dose rate in cGy/hr and total urethral
treatment dose in Gy to measured points along the urethra. The mini detector is
operated in spectroscopy mode, allowing the measurements to be sensitive enough
to detect the low radiation levels emitted from the iodine-125 seeds, separating the
photopeaks from the low energy noise. However, it is also sensitive to
electromagnetic radiation present in the environment and needs to be shielded to
avoid noise in the readings. This shielding can be achieved by covering the detector
and associated amplification electronics in thin aluminium strips. A Monte Carlo study
into the effects of the aluminium strips on the performance of the device is required.
The research goals of the study are:
•

Use the GEANT 4 toolkit to model the dosimetry system detector in a liquid
water phantom

•

Investigate the anisotropy of the detector and compare the depth dose
response to the equivalent dose in water, as simulated, and calculated using
the TG 43 formalism

2

•

Model the effects of placing the aluminium screening sheets over the
detector on the device performance (angular anisotropy and depth dose
response)

•

Model the effects of using the device with a sub-optimal depletion region in
the detector

3

2. Literature Review
Real time transrectal ultrasound guided transperineal placement of permanent
interstitial and sources is one of the treatment modalities available for early stage
prostate cancer [2].

2.1 The Prostate
The prostate is one of the organs that form the male reproductive system. Its main
function is to produce a liquid that protects and enriches sperm. It is located
immediately below the bladder and in front of the rectum, as shown in figure 2-1. It
is doughnut shaped, surrounds the beginning of the urethra and is approximately
the size of a walnut [1].

Figure 2-1 Diagram of the prostate gland relative to the bladder, rectum and urethra

4

2.2 Brachytherapy
Brachytherapy is derived from the Greek word brachys meaning short. Brachytherapy
is a radiation therapy modality where the radiation source is placed either within or
close to the tumor or tissue intended to be irradiated. The short range of the
radiation, with a rapid fall off in dose produced by brachytherapy sources, allows
for a large amount of dose to be delivered to the intended region whilst sparing
surrounding healthy tissue. Brachytherapy sources deliver a non- uniform irradiation
of the target volume. This is in contrast to teletherapy, derived from the Greek word
teles, meaning far away. In teletherapy, the radiation source is placed at a great
distance from the tumor and produces a close to uniform irradiation of the
target volume. Teletherapy modalities, such as external beam radiotherapy, may
be complemented with a brachytherapy treatment to provide a dose “boost” to the
tumour.
Brachytherapy typically consists of; implanting the sources directly in the target
tissue (interstitial brachytherapy) or placing the source at a short distance (a few
millimetres) from the target tissue, in body cavities (intracavitary brachytherapy) or
externally on structures (surface plaques or moulds) [1] [3].
There are two implant modalities used in brachytherapy; permanent and temporary
implants. Temporary implants, such as those used in high dose rate (HDR)
brachytherapy, contain a high activity, low energy x-ray source that is implanted in the
body for a short period of time. Permanent implants, such as those used in low dose

5

rate brachytherapy, contain low activity, low energy x-ray sources, which are
permanently implanted into the patient.

2.2.1 History of Prostate Brachytherapy
The first reported radiotherapy treatment of prostate cancer was performed via
brachytherapy in Paris, 1909, using radium capsules inserted into the prostatic
urethra [4] [5]. The following year, the Memorial Sloan Kettering Cancer Centre
(MSKCC) in New York performed prostate brachytherapy using radium needles
which were inserted through the perineum. This approach became the most common
method of radiotherapy for prostate cancer at the time [5].
In the late 1960’s, the MSKCC used nuclear reactors to develop iodine-125 seeds
which were implanted using the retropubic approach [6]. This approach involved
implanting seeds to cover the estimated volume of the prostate, however, due to
limited technology in imaging and computers, this often resulted in significant
regions of the prostate being under dosed. Through experience, the optimal dose
for the prostate was defined to be between 140 and 160 Gy in the 1970’s [7]. The
American Association of Physics in Medicine formed Task Group 43 (TG 43) to
provide recommendations for dosimetry of brachytherapy to standardise the way
treatments were performed and to provide a guideline for treatment reporting.

6

2.3 Permanent Seed Brachytherapy
Low dose rate brachytherapy seeds typically contain radioactive palladium-103 or
iodine-125 and are generally less than five millimetres in length and less than one
millimetre in diameter, similar to the size of a rice grain. The low energy radiation
emitted is almost entirely absorbed by the prostate itself. The implant is tailored to
the shape and size of the prostate and is optimised to provide a maximum dose to
the prostate while minimising dose to the surrounding organs such as the urethra
and the rectum. Typically 90 to 120 seeds are used for each treatment plan. The
seeds are implanted into the prostate through pre-loaded needles which are
inserted into a guiding needle template at the co-ordinates determined in the
treatment plan [2] [8] [9].
In comparison to external bream radiotherapy or prostatectomy, equivalent
biochemical control rates for permanent seed implantation brachytherapy for
patients with low risk prostate cancer have been confirmed and found to be
favourable [10] [11] [12].
Interstitial brachytherapy exhibits a different side effect profile in comparison to
external beam radiotherapy or radical prostatectomy; however there has been little
emphasis on the evaluation and comparisons of side effect and complications [8].
Acute urinary symptoms, such as dysuria, frequency, urgency weak stream and
nocturia are the most common side effects following permanent implant
brachytherapy [2]. These symptoms typically peak between one to three months
after implantation, with patients generally returning to baseline within one year.
7

Radiation damage to the rectum is uncommon following permanent seed implantation
[5] [13].
Purely uniform seed loading approaches in prostate brachytherapy, can cause an
intolerably high central dose along the urethra. The American Association of Physicist
in Medicine, Task Group 56, recommends that treatments plans be designed to
place seeds peripherally, as illustrated in figure 2-2, to improve dose homogeneity
and avoid unnecessary radiation damage to the urethra [14].

Urethra

Peripherally loaded seeds
Figure 2-2 Planning image of the prostate with peripherally loaded
iodine-125 seeds
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Medical complications may arise from errors during the seed implantation. There are

several factors which may contribute to the misplacement of seeds such as [2]:
•

Seeds may drift along their path

•

Blood flow may alter seed position

•

Oedema may alter the size and shape of the prostate

•

Gland motion may occur throughout the treatment [2] [14]

•

Guiding needles may diverge during insertion as they penetrate through
different layers of tissue

The misplacement of seeds may lead to regions of overdose, which may result in
increased medical complications or regions of under dose, leading to future
reoccurrence of the disease [14]. There is a need for the dose to the urethra to be
monitored in real time during seed implantation to manage dose to the prostate
and critical organs such as the urethra. The American Brachytherapy Society (ABS)
recommend that the dose to the urethra be monitored at the centre of the urethra
in five millimetre intervals from the base to the apex of the prostate, reporting
the maximum and mean values, for correlation with urethral toxicity [15] [16].
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2.4 Post-Implant Dosimetric Techniques
Post-implant dosimetric analysis is an important component of permanent seed
implants as it ensures that the dose coverage of the prostate is adequate and that the
dose to surrounding organs is minimal. This provides an early opportunity for further
treatment if required. Several techniques have been employed involving various
imaging modalities such as x- ray radiographs, computer tomography (CT), magnetic
resonance imaging (MRI), ultrasound (US) or a combination of techniques.

2.4.1 X-ray radiographs
X-ray radiographs for post-implant dosimetry are employed using a set of two films,
such as in the stereo-shifted pair technique and orthogonal pair technique, or three
films. One disadvantage in using x-ray imaging for post-implant dosimetry is the inability
to image the prostate and surrounding soft tissue anatomy. X-ray radiographs for post
implant dosimetry techniques are becoming obsolete.

Stereo-shifted Radiographs
The stereo-shifted method involves taking two radiographs of roughly the same
anatomy, with the x-ray tube shifted a certain distance, changing the angle between the
two exposures, as illustrated in figure 2-3. The seed co-ordinates can be determined
using the known angle of shift. The stereo-shift method is preferred when sources
cannot be easily identified by orthogonal films, when there are a large number of
seeds, or where some seeds are masked by overlying bone [16]. It may not be
10

possible to identify all seeds due to a high density of seeds or patient movement in
between radiographic exposures. This technique is also very time consuming when
there are a large number of seeds to be identified [17].

Figure 2-3 Illustration of stereo-shifted radiographs

Orthogonal radiographs
Orthogonal radiographs are taken at orthogonal angles (right angles) to each other,
such as anterior-posterior and lateral, with the central axis at approximately the
middle of the implant, as illustrated in figure 2-4. Once seeds are identified on both
films, three-dimensional co-ordinates of each seed location can be determined.
As the films are orthogonal, there is no common anatomy to assist in analysis. The
accuracy of orthogonal films is generally better than that of the stereo-shift
method [16].

11

Figure 2-4 Illustration of orthogonal radiographs

Three Films Technique
The three films technique is similar to that of the stereo-shifted technique but uses
three radiographs instead of two, as illustrated in figure 2-5. The three films are
taken isocentrically at 45˚, 0˚ and -45˚ about the gantry axis of the imaging system.
The three films technique was developed to speed up the process in identifying
large numbers of implanted seed [17]. Advantages of the three films technique
include; improving the accuracy, consistency and time of seed identification process.
However, as with x- ray imaging, the inability to identify the prostate and surround
anatomy is a major drawback [17].

12

Figure 2-5 Illustration of the three films technique

2.4.2 Computer Tomography Imaging
CT scanners first became available clinically in the 1970’s [18]. The majority of postimplant imaging performed today is CT based due to the relatively low expense
and excellent visualisation of seeds [8]. CT imaging involves acquiring thin, crosssectional images of the target using x-rays. The x-ray beam and detector rotate
around the patient, with the detector collecting a large number of x-ray attenuated
measurements, which are then used to reconstruct cross-sectional images. CT
images provide electron density information, however, this information is not
currently used in brachytherapy dosimetry calculations. CT imaging lacks the ability
to delineate the prostate gland and urethra and intra-operative imaging capabilities.
Another limitation of CT is patient positioning, which is the supine position for the
13

post-implant CT in comparison to the dorsal lithotomy position for the implantation
procedure [1] [19]. An illustration of the cross section of a CT scanner is illustrated in
figure 2-6.

Figure 2-6 Illustration of the cross section of a CT scanner

2.4.3 Magnetic Resonance Imaging
MRI was first proposed as a method for detecting tumours around 1971, many
years before it became the three-dimensional imaging tool in use today [20]. In
contrast to CT, MRI provides excellent soft tissue contrast and has been used for
post-implant dosimetry [20]. MRI involves applying a large uniform magnetic field to
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the patient, which aligns the hydrogen atoms found in water in the body. A Radio
Frequency (RF) pulse is applied to the patient, which induces resonance (spinning) in
the hydrogen atoms. As the hydrogen atoms return to their aligned state they emit
RF energy. After a defined period of time, the emitted RF signals are measured.
Hydrogen atoms in different materials realign at different rates which allows for
contrast within the images. The resonant frequency is a function of the applied
magnetic field. A Fourier transformation is applied to the data to obtain a crosssectional image. MRI is more useful than CT in defining contrast between the different
types of tissues, allowing for a more accurate volume of the prostate to be
determined. However, MRI is not suitable alone due to the inability to distinguish
seed locations as they do not image well. Like CT, MRI is also commonly nonintraoperative [18] [20]. An illustration of the cross section of a MRI unit is displayed
in figure 2-7.
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Figure 2-7 Illustration of an MRI unit

2.4.4 Ultrasound
Ultrasound is mostly used for seed placement guidance, and can be used to define the
peripheral zone of the prostate quite accurately, which is where most prostate cancers
originate from [21]. Ultrasound images are formed using high frequency sound waves
and their echoes. The ultrasound machine transmits high frequency, typically 1 –
20 MHz, sound pulses into the body using piezoelectric crystals contained in the
transducer probe of the ultrasound machine. Piezoelectric crystals will vibrate rapidly
when an electric current is applied, producing sound waves. The sound waves travel
through the body and hit a boundary between tissues, such as between soft tissues
and bone. Some of these waves will be reflected from the interface, whilst others will
16

travel further until they reach another boundary, where they may be reflected. The
reflected waves are detected by the probe and relayed to a processor. Using the speed
of sound in tissue and the time for the echo to return, the machine can calculate this
distance from the probe to the organ. The machine displays the distance and
intensities of the echoes on the screen forming a two-dimensional image [21].
Trans-Rectal Ultrasound
Trans-rectal ultrasound (TRUS) was introduced in 1971 to provide information on the
size and shape of the prostate. Since then, TRUS has become the main imaging
modality for diagnosis and real-time imaging during guidance for brachytherapy
procedures [20]. TRUS uses a TRUS probe which is inserted into the rectum, allowing
the probe to be close to the prostate, as shown in figure 2-8. Ultrasound images of the
prostate are then obtained. The ultrasound probe is mounted to an assembly that is
attached to either the floor or operating table to prevent movement. These generally
consist of the TRUS probe attachment unit, a needle template and a stepper to
advance or withdraw the transducer. The drawback with TRUS is that the images
degrade significantly as the number of seeds implanted increases, make it very difficult
to identify seeds [20]. Additionally, air artifacts may also be mistaken for seeds [22].

17

Figure 2-8 Diagram of a trans-rectal ultrasound in the rectum

Three-dimensional Ultrasound
Three dimensional ultrasound images are obtained from one-dimensional arrays to
collect multiple two-dimensional images which are then reconstructed by compiling
progressive two-dimensional images using three-dimensional software [20] [23].
There are three common methods for acquiring three-dimensional scans; pull-back
method, tilt three-dimensional method and rotational method [23] [24].

2.4.5 Image Fusion
Each imaging modality has their advantages and disadvantages. “Fusing‟ images
from different modalities optimise the information available for post-implant analysis
[25]. Image fusion typically involves combining an imaging modality that offers good
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seed identification, such as x-ray radiograph or CT, with an imaging modality that
accurately delineates the prostate from other critical organs, such as MRI or
ultrasound. Image fusion requires a transformation matrix to be determined for a
minimum of three data points. The more data points u s e d , the more accurate the
resultant image. Data points commonly used in prostate brachytherapy include;
marker seeds, urethral surface and multiple seed locations. Limitations of image
fusion include errors introduced through changes in patient positioning and distortion
[25] [26].

2.4.6 Comparison of images of the prostate from different imaging
modalities
Presented in figure 2-9 - figure 2-12 are images of the prostate obtained by x-ray, CT,
MRI and ultrasound respectively. It can be seen that the prostate is not visible on the
x-ray image, and hence cannot be used as a sole imaging modality for planning or
post-implant dosimetry. The CT image shows the prostate, rectum and bladder quite
clearly but the overall quality of the image in terms of organ contrast is inferior to the
MRI image, which clearly shows the prostate and surrounding organs. The ultrasound
image does not clearly show the prostate or surrounding organs.
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Figure 2-9 X-ray image of the a prostate following an I-125 LDR brachytherapy permanent implant
procedure [27]

Figure 2-10 CT image of the prostate [28]
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Figure 2-11 A MRI image of the prostate where A is the right hip, B is the bladder, C is the left hip, D
is the prostate and E is the rectum [29]

Figure 2-12 An ultrasound image of the prostate [30]

21

2.5 Intraoperative Dosimetric Techniques
Post-implant dosimetry has its disadvantages as it is typically completed one month
after the implant procedure and therefore does not allow for correction if any errors
are made. American Brachytherapy Society (ABS) recommends that “one should
strive for on-line real time Intraoperative dosimetry to allow for adjustments in seed
placement to achieve the intended dose” [26].
The Department of Medical Physics and the Department of Radiation Oncology at The
Memorial Sloan-Kettering Cancer Centre (MSKCC) in New York have developed a
system that utilises ultrasound and fluoroscopic images to monitor the position of
implanted seeds, during the implantation procedure [2]. Ultrasound images of the
prostate prior to insertion are obtained. Following the insertion, the prostate is
scanned using ultrasound from the base to the apex in 0.5 cm intervals. These images
are transferred to a computer where the prostate contours and urethra are digitised
on each image. Fluoroscopic images of the lead markers and seeds are obtained at
three angles using a C-arm fluoroscopy unit, which are superimposed onto the
ultrasound prostate images using computer reconstruction. The entire process takes
approximately 5 – 10 minutes [2] [31] [32], allowing a comparison of planned and real
positions of seeds after a portion of seeds have been implanted, followed by a plan
adjustment if required [32]. However, currently it has been used in the operating
theatre just after implant completion rather than in real time during implantation.
Cold spots in the treatment can be avoided by implanting loose seeds (individual
seeds) immediately after implantation into regions of low dose [32].
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2.6 Brachytherapy Seeds
Amersham Health’s Oncoseed 6711 is a commonly used seed for low dose rate
permanent brachytherapy. Iodine-125 is adsorbed onto a silver rod and is
encapsulated in a titanium capsule. The iodine-125 based seed is 4.5 mm in length,
the silver rod has a diameter of 0.5 mm and the total diameter of the seed with the
titanium encapsulation is 0.8 mm [33]. A schematic diagram of Amersham Health's
Oncoseed 6711 is presented in figure 2-13.

Figure 2-13 Schematic diagram of Amersham Health’s Oncoseed 6711 [33]

Iodine-125 has a half life of 59.43 days and the principal photon emission are at
27 keV and 31.4 keV x-rays and a 35.5 keV gamma. The iodine-125 seed will also
emit 22.1 keV and 25.2 keV fluorescence x-rays due to interactions of the iodine-125
with the silver rod [33]. The spectrum from an iodine-125 seed is presented in figure
2-14. A photograph showing a size comparison of iodine-125 seeds and a five cent
coin are illustrated in figure 2-15.
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Figure 2-14 Illustration of the energy spectra emitted from an iodine-125 seed using a CdTe detector

Figure 2-15 Photograph of iodine-125 seeds with a five cent coin for size comparison
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2.7 TG-43 Protocol
The American Association of Physicists in Medicine’s (AAPM) Task Group 43 published
a protocol TG-43, in March 2004, for brachytherapy dose calculation formalism,
based on the findings of an interstitial brachytherapy collaborative working group.
This protocol details dose calculation formalism for cylindrically symmetric line
sources (2D) and point sources (1D) [34].

2.7.1 2D dose calculation formalism
Brachytherapy seeds used for permanent low dose rate brachytherapy can be
considered as cylindrically symmetric line sources for a 2D formalism. The 2D dose
rate equation is: [34]

(2.1)
Where r is the distance in centimetres from the centre of the active source to the
point of interest, r0 denotes the reference distance which is specified to be 1 cm in
this protocol, θ denotes the polar angle specifying the point of interest P (r, θ),
relative to the longitudinal axis and Ď(r, θ) is the dose rate at the point of interest.
The reference angle, θ0, defines the source transverse plane and is specified to be 90°
or π/2 radians. SK is the air kerma strength, Λ is the dose rate constant, GL(r,θ) is
the geometry function, gL is the radial dose function and F(r, θ) is the anisotropy
function. The subscript L indicated on the geometry function and radial dose
function indicates that a line source approximation was used for the geometry, and
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may be replaced with a “p” for a point source calculation [34]. An illustration of the
co- ordinate system used in TG-43 is illustrated in figure 2-16.

Figure 2-16 Co-ordinate system used in TG–43, adapted from [34]
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Air kerma Strength (S k )
Air-kerma strength is a measure of brachytherapy source strength, which is specified in
terms of the air-kerma rate at a point along the transverse axis of the source in free
space. The air-kerma strength, S K , is given by the air kerma rate, K˙ δ (d) in vacuum due
to photons of energy greater than δ at distance d, multiplied by the square of this
distance, d2 and is given by:

(2.2)
The quantity d is the distance from the source centre to the point of K˙ δ (d) on the
transverse plane of the source and is recommended to be 1 metre. Air kerma strength
has units of µGym2h-1 which is often denoted by the symbol U, where
1 U = 1 µGy m2 h-1 = 1 cGy cm2h-1.
Dose Rate Constant (Λ)
The dose rate constant, Λ, is defined as the dose rate at a distance of 1 cm along
transverse axis of the source per unit air kerma strength (U) in a large water phantom.
The dose rate constant of a brachytherapy source is given by:

(2.3)
The dose rate constant has units of cGy h-1 U-1 and represents the effects of scattering
and attenuation within the transport medium.
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Geometry Function (G(r,θ))
The Geometry Function (G(r,θ)) takes into account the spatial distribution of
radioactivity within the source and the slump of the photon fluence with distance from
the source (inverse square-law correction). For a point source, the geometry function
is the inverse square law:

(2.4)
For a line source, the angle of the source with respect to the point of calculation, θ, the
length of the source, L, and the angle subtended by the tips of the line source to the
point of measurements, β, are taken into account, as shown in figure 2.16, and is given
by:

(2.5)
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Radial Dose Function (g(r))
Radial dose function, g(r), takes into account the fall off of dose rate along the
transverse axis due to absorption and scattering in the medium. It can also be
influenced by filtration of photons by the encapsulation and source materials. The
radial dose function is defined only on the transverse axis (i.e. where θ=π/2 or 90°) and
is, by definition, unity at r = 1cm, i.e., g(1cm) = 1. The subscript X is substituted by L for
a line source or P for a point source. The radial dose function is given by:

(2.6)
Anisotropy Function (F(r,θ))
The Anisotropy Function, F(r,θ), takes into account angular variation of photon
absorption and scattering in the encapsulation and the medium at different distances
and angles from the source and is given by:

(2.7)
Similar to g(r), applying the geometry function in the above equation is suppressing the
effect of inverse square law on the dose distribution around the source.
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TG 43 Data
The data for the Amersham Health’s Oncoseed 6711, as published in TG 43, is
presented in table 2-1 and 2-2.
The dose rate constant, Λ, is 0.965 cGy h-1 U-1.
The radial dose function, g(r), for an Amersham Health’s Oncoseed 6711 for a line and
a point source can be found in Table II of TG 43 and is presented in table 2-1.

r (cm)

Line source approximation
L= 3.0 mm

Point source
approximation

0.10
0.15
0.25
0.50
0.75
1.00
1.50
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00

1.055
1.078
1.082
1.071
1.042
1.000
0.908
0.814
0.632
0.496
0.364
0.270
0.199
0.148
0.109
0.0803

0.696
0.853
0.982
1.048
1.036
1.000
0.912
0.819
0.636
0.499
0.367
0.272
0.200
0.149
0.110
0.0809

Table 2-1 Table II adapted from TG 43 which lists the radial dose function g(r) for Amersham Health’s
6711 I-125 seed obtained from Monte Carlo simulations, interpolated data are in bold.

The anisotropy function, F(r,θ), for an Amersham Health’s Oncoseed 6711 can be
found in table V of the TG 43 report and is presented in table 2-2.
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r (cm)

Polar angle
θ (degrees)

0.5

1

2

3

4

5

0
5
10
20
30
40
50
60
70
80
Øan(r)

0.333
0.400
0.519
0.716
0.846
0.926
0.972
0.991
0.996
1.000
0.973

0.370
0.429
0.537
0.705
0.834
0.925
0.972
0.991
0.996
1.000
0.944

0.442
0.497
0.580
0.727
0.842
0.926
0.970
0.987
0.996
1.000
0.941

0.488
0.535
0.609
0.734
0.846
0.926
0.969
0.987
0.995
0.999
0.942

0.520
0.561
0.630
0.752
0.848
0.928
0.969
0.987
0.995
0.999
0.943

0.550
0.587
0.645
0.760
0.852
0.928
0.969
0.987
0.995
0.999
0.944

Table 2-2 Table V taken from TG-43 which lists the anisotropy function F(r,θ) for Amersham Health’s
6711 I-125 seed, data has been obtained from Monte Carlo simulations

The need for dose verification with physical detectors is a necessity to reduce side
effects and improve the quality of the implant. The complexity of dosimetry for I-125
seeds is due to the low dose rates, anisotropy of dose about the seeds and rapidly
diminishing dose with distance from the seeds. In vivo measurements with traditional
detectors, such as MOSFETs or diodes, are energy dependent in this spectral range and
are not sensitive enough to provide fast, real-time measurements. For MOSFETS, the
sensitive volume is too small, requiring a large exposure time to provide an adequate
reading. Diodes traditionally operate on current generation from interactions with the
induced currents measured for the dosimetry, however, the induced currents are too
low for application in low dose rate brachytherapy. In-vivo dosimetry demands
miniature, high sensitive and tissue equivalent dosimeters. This can be achieved
through the use of a mini silicon detector operating in spectroscopy mode.
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2.8 Semiconductor detectors
Semiconductor detectors have recently been adopted in radiotherapy dosimetry due
to their relatively small size, allowing for in-vivo measurements in real time. They are
able to work in unbiased (passive) and biased (active) modes; they have a high
efficiency of radiation induced charge collection under low voltage due to their high
purity and are reproducible in large batches. In addition to this, semiconductor
detectors are useful in low energy dosimetry due to the low energy required for the
creation of electron-hole pairs, typically between 1 to 4 eV depending on the
semiconductor material, making them suitable for low dose rate brachytherapy [35].
Silicon is the most suitable semi-conductor material for room temperature and body
temperature radiation dosimetry. Silicon microelectronics are becoming more
advanced and the production of silicon detectors is cheaper than other
semiconductor detectors [35].

2.8.1 Energy Band Structure
Semiconductors are materials which have a conductivity much higher than insulators,
but much lower than metals when measured at room temperature. The temperature
dependence of the conductivity of semiconductors also distinguishes semiconductors to
metals. While metals retain their metallic conductivity even at low temperatures,
semiconductors are transformed into insulators at very low temperatures.
Semiconductors can be made from pure elements, such as silicon or germanium, or
compounds, such as gallium arsenide. The crystal structure of silicon and germanium is
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the same as that of diamond (cubic), which are crystalline solid structures, with each
atom surrounded by four neighbouring atoms.
Individual atoms contain electrons that orbit the nucleus with distinct energies [36]
[37]. Energy bands are regions of discrete energy levels that are so closely spaced they
form a continuum of allowed energy states, as the periodic arrangement of atoms in
close proximity in the crystal cause the electron wave functions to overlap. As the Pauli
Exclusion Principle states that no two electrons can occupy the same state, the
degeneracy in the outer atomic shell energy levels breaks to form several discrete
energy levels separated only slightly from each other [36] [37]. The forbidden energy
gap is a region in which there are no available energy levels for electrons to occupy.
In the absence of thermal excitation, all of the electrons are in the ground state
configuration. The conduction band is completely empty while the valence band is
completely full. The energy range in between the conduction and the valence band is
known as the band gap. Thermal excitation is a process where lattice vibrations
provide enough energy to lift electrons from the valence band to the conduction
band, which creates a space in the valence band known as a hole. The hole in the
valence band acts as a positively charged carrier and can drift when an electric field
is applied. The electrons in the conduction band are free to migrate through the
crystal and also contribute to the electrical conduction when an electric field is
applied. The combination of an electron in the conduction band and a hole in the
valence band form an electron-hole pair. In an intrinsic (pure) semiconductor, the
number of electrons in the conduction band, n, is equal to the number of holes in
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the valence band, p [36] [37]. An illustration of the energy band structure is
presented in figure 2-17.

Figure 2-17 Illustration of the energy band structure in semiconductors

The probability per unit time that an electron-hole pair will be thermally generated
is given by:

(2.8)
Where T is the temperature in Kelvin, C is the material dependent constant, Eg is the
band gap energy and k is the Boltzmann constant [37].
By introducing group III or group V elemental impurities into an otherwise pure silicon
crystal, it is possible to modify the electrical conductivity of an intrinsic semiconductor.
These impurities may be introduced by different means of doping and create a hole in
the crystal for group III dopants or donate an electron for group V dopants, thereby
making energy levels available in the band gap that are forbidden in an intrinsic
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semiconductor. These semiconductors are known as p-type and n-type extrinsic
semiconductors respectively [36] [37].
By introducing a pentavalent (valency of 5) element from Group V in the periodic
table, such as arsenic, phosphorus or antimony, into a pure silicon crystal, four out of
five electrons in the outer shell will bond with the silicon crystal, with one
electron left unbound, as illustrated in figure 2-18. This electron can be easily
excited into the conduction band [36] [37].
free electron

phosphorus

Figure 2-18 A silicon crystal doped with pentavalent element phosphorus creating a free electron

By introducing a trivalent (valency of 3) element from Group 3 of the periodic table
such as boron, aluminium or indium into a pure silicon crystal the Group 3 element
accepts an electron from the lattice to complete the covalent bonding and leaves a
hole in the lattice, as illustrated in figure 2-19, that is free to contribute to the
conduction, or, at low temperatures is bound to form a hydrogen like atom. A nearby
electron can tunnel into this hole and displace it further away from the doping
element. Extra states are created in the band gap, allowing for easier excitation of
valence band electrons, leaving mobile holes in the valence band [36] [37].
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hole

aluminium

Figure 2-19 A silicon crystal doped with trivalent element aluminium creating a hole [37]

2.8.2 P-n Junctions
A p-n junction is formed at the boundary between a p-type and n-type
semiconductor. The junction behaves differently than either of the materials alone
in that a current can flow quite easily in one direction from positive to negative,
whereas is limited to a small leakage current from negative to positive. At the
junction, some of the free electrons in the n-type semiconductor may diffuse across
the junction and combine with holes in the p-type semiconductor. Holes may also
diffuse from p-type to n-type. The combining of electrons and holes depletes the
holes in the p-type semiconductor and electrons in the n-type semiconductor near
the junction, creating a region that is depleted of charge carriers, as illustrated in
figure 2-20 [36] [37]. A double layer of charge at the junction is formed due to a gain
in electrons and a loss in holes which creates negatively charged acceptors and a loss
in electrons when they combine with the holes which creates the positively charged
donors.
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p-type material

n-type material

Empty holes

Free electrons

Resultant
layer of
negative ions

Resultant
layer of
positive ions

Figure 2-20 Schematic diagram of a p-n junction
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2.9 Mini-Silicon Spectroscopy Detectors
The dose delivered by radioactive seeds used in permanent low dose rate
brachytherapy is difficult to measure due to the low dose rates, low energy of the
source, anisotropy of the dose surrounding the seeds, confined spaces and the
rapidly diminishing dose with distance from the seeds. Current commercial in vivo
dosimeters such as MOSFETS and diodes in this spectral range are not sensitive
enough to the low dose rate and energy emitted from iodine-125 seeds [2].
The Centre of Medical Radiation Physics (CMRP) at The University of Wollongong
(UOW) in Australia has developed an intra-operative dosimetry system, the urethral
mini-dosimeter, based on in vivo spectroscopy [2][35][38][39][40]. The system is
based on a mini-silicon detector probe that has been designed to be small and
flexible enough to be placed into a Foley catheter and into the urethra during
implantation. The probe connects to a data acquisition unit which displays in real
time the point urethral dose rate and extrapolated total dose after infinite time (full
treatment). The intraoperative dosimetry system with the detector in a Foley
catheter is presented in figure 2-21 and the mini silicon detector is presented in
figure 2-22.
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Figure 2-21 The urethral mini-dosimeter, the silicon detector probe in a Foley catheter

Figure 2-22 The silicon detector probe attached to the preamplifier

The silicon detector at the tip of the probe is 3.5 mm long, 0.8 mm wide and 0.35
mm in height, as illustrated in figure 2-23.

Figure 2-23 Silicon detector design featuring a planar p+ n n+ diode

The silicon detector is a planar p+ n n+ diode and has been designed to provide highly
isotropic measurements under full depletion, with the depletion layer spreading
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laterally and vertically with increased reverse bias, as shown in figure 2-24. Full
depletion is reached below 25V reverse bias, with an operating reverse bias set to 30V.

Figure 2-24 The expected depletion behaviour of the mini-silicon detector with an increase in reverse
detector bias

As shown in figure 2-25, the detector is encapsulated in a polyamide film, Kapton,
using CMRP proprietary patented

‘drop in’ technology [41] which provides a

sealed waterproof cover for the detector and surface mounted electronics, which will
also allow for sterilisation in clinical use. The aluminium shields provide shielding
from the electromagnetic environment, which is crucial prior to the initial
amplification stage to reduce any unwanted “electromagnetic noise” in the
signal. The Field Effect Transistor (FET) is directly coupled to the detector and
provides immediate amplification of the pulse with minimal loss of signal.
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Figure 2-25 Schematic diagram of the mini silicon detector probe (figure is preparatory of
CMRP and should not be reproduced without CMRP permission)

Brachytherapy seeds containing I-125 or Pd-103 have a very distinct energy spectrum
of known energies. Using these known energies, measurements of the photopeak
can be used for dosimetry or distance measurements between the detector and
source.
This can be achieved with a mini-silicon detector, with an active volume less than 1
mm3, operating in spectroscopy mode. At the low energies of I-125 (approximately
27 keV) most of the energy loss occurs via the photoelectric effect. Energy loss due
to the Compton effect is minimal, but the Compton cross-section is significant. As
the emitted photons penetrate through tissue, they will be attenuated in intensity by
varying amounts [2] [35] [38]. The intensity (I) of a photopeak at a distance (r) from the
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point source is dependent on the attenuation co-efficient (µ) for photons at a distinct
energy, penetrating a constant medium as show in equation 2.9 [16]:

(2.9)
Using the above method, the ratio of peak heights of varying energy photopeaks
within an I-125 spectrum, or area under the peaks in an obtained spectrum will yield
the distance from a point source to the detector. The area under a chosen photopeak
will be proportional to the deposited dose at the position of the measurement and
the number of counts in the photopeak of a measured spectrum can be related to
the dose rate at the point of measurement. Using a particular photopeak for dosimetry
means that the detector does not have to be tissue equivalent and using the detector
in spectroscopy mode meets the sensitivity requirements for the low dose rates [2]
[35] [38]. A study by Cutajar, et al, showed that the mini-silicon dosimetry system
measure doses to an accuracy of 5% to the expected dose for iodine-125 seeds at
distances of 0.5 – 2.0 cm [38]. More details on spectroscopy dosimetry of
brachytherapy seeds can be found in D Cutajar, PhD thesis [42].
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2.10 Low Energy Photon Interactions
Brachytherapy seeds containing Pd-103 or I-125 emit low energy photons, which
may interact with tissue via the following mechanisms; photoelectric effect, Compton
(incoherent) scattering and coherent scattering. The probability of an interaction
occurring is dependent on the cross-section of the interaction centre [43]. The
probability of the photoelectric effect occurring is described by the mass absorption
coefficient, which varies greatly with atomic number (Z) of the target material and
the energy of the photon. The photoelectric mass absorption coefficient is
approximately proportional to Z3. The probability of the Compton effect is much
less dependent on Z [16].

2.10.1

Photoelectric Effect

The photoelectric effect occurs when a photon strikes an atomic electron, with the
electron absorbing all of the photons energy. The orbital electron is ejected from the
atom as a photoelectron, with kinetic energy (EK) equal to the energy of the
incident photon (hv) minus the binding energy (EB) of the electron, as shown in
equation 2.10 [43][44]:
EK = hv - EB

(2.10)

After the electron has been ejected from the atom, a vacancy is created in the shell,
leaving the atom in an excited state. The vacancy can be filled by an outer orbital
electron with the emission of characteristic x-rays. Auger electrons (monoenergetic
electrons) may also be emitted due to internal absorption of characteristic x-rays.
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When an electron from the L shell drops to fill a vacancy formed by K-shell ionization,
the resultant X-ray photon may not be emitted from the atom. If this photon strikes a
lower energy electron, for example an M-shell electron, this outer electron may be
ejected as a low-energy Auger electron. The photoelectric effect can take place by
interactions with electrons in the K, L, M or N shells [16] [43]. An illustration of the
photoelectric effect is presented in figure 2-26.

Figure 2-26 Illustration of the photoelectric effect, adapted from Khan [16]

The photoelectric effect is most significant for photon energies less than 100 keV in
water [16]. For the photoelectric effect to take place, the incident photon must have
energy greater than the binding energy of the ejected electron. The photoelectric
effect occurs most readily when the energy of the incident photon is similar to that
of the binding energy of the ejected electron [16].
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2.10.2

Compton Scattering

Compton (incoherent) scattering occurs when a photon interacts with an atomic
electron as if it were a free electron, i.e. the energy of the photon is significantly
greater than the binding energy of the electron. The photon loses some of its energy to
the electron, with the electron is deflected through an angle. The amount of energy
transferred to the electron from the photon is dependent on the initial photon energy
and the angle of deflection. The Compton effect provides a significant proportion of
interactions but little energy loss per interaction for low energy photons (energies less
than 100 keV) in water [16] [44]. An illustration of the Compton effect is shown in
figure 2-27.

Photon hv’

Incident photon hv0

Compton electron

Figure 2-27 Illustration of the Compton effect, adapted from Khan [16]
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By applying the laws of conservation of energy and momentum, the resulting
energy for a photon with energy hv which is Compton scattered by a free electron, is
shown in equation 2.11:
hv’ =

hv0
1 + hv0 (1 – cos θ)
m0c2

(2.11)

Where m 0 c2 is the rest energy of the electron (0.511 MeV), θ is the angle of deflection
of the photon, hv 0 is the initial photon energy and c is the speed of light in a vacuum
[16].
If the photon makes a direct hit with the electron, the electron will travel forward (φ =
0 degrees) and the scattered photon will be completely recoiled (θ = 180 degrees)
after the collision. This will result in the maximum energy loss for the incident photon,
the maximum energy loss through Compton effects are listed in the table 2-3 for the
energies of iodine-125.
Energy (keV)
27
31
35.5

Maximum Energy Loss (keV)
2.6
3.3
4.3

Table 2-3 Maximum energy loss through the Compton effect for iodine-125 emissions in water

2.10.3 Coherent Scattering
Coherent scattering, also known as classical or Rayleigh scattering, occurs when a
photon interacts with a bound orbital electron, with the photon appearing to be
deflected at an angle with no energy is loss. The interaction causes the electron to
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oscillate, which reradiates the energy at the same frequency as the incident photon.
The scattered photon has the same wavelength as the incident photon [16] [44].
Thompson scattering is another form of coherent scattering, where the effects of
scattering are shared over all of the electrons in an atom, with all of the electrons
vibrating in phase. A single photon is emitted when all of the electrons return to
stable state. Both Thompson and Rayleigh scattering are coherent scattering
mechanisms that result in no energy loss to the scattered photons, but still
contribute to the total energy interaction cross-section [43] [44]. An illustration of
coherent scattering is presented in figure 2-28.

Figure 2-28 Illustration of coherent scattering adapted from Khan [16]
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2.11 Low Energy Electron Interactions
When a photon interacts with a medium by either a photoelectric or Compton
process, electrons are set in motion and may interact with tissue to give rise to
bremsstrahlung x-rays or characteristic x-rays [43].

2.11.1 Bremsstrahlung Radiation
Bremsstrahlung comes from the German words bremsen, which means to
decelerate, and strahlung, which means radiation [43]. The process of bremsstrahlung
is the result of the radiative collision interaction between a high speed electron and
a nucleus [16]. When an electron passes close to the nucleus of an atom, it may be
deflected from its path by the action of Coulomb forces of attraction. This can result
in an energy loss for the electron and the production of bremsstrahlung radiation
through conservation of energy [16] [44]. The probability of this interaction increases
as the distance of the electron to the nucleus decreases [43]. The maximum energy of
the bremsstrahlung photon can be no more than the incident electron energy and a
spectrum of photon energies below this value is produced [43]. The production of
bremsstrahlung radiation is illustrated in figure 2-29.
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Figure 2-29 Illustration of the production of bremsstrahlung radiation, adapted from Khan [16]

2.11.2

Characteristic Radiation

Electrons may also interact with low orbital electrons to produce characteristic xrays. The electron interacts with the target atom by ejecting an inner orbital
electron, such as a K, L or M electron, leaving the atom ionised. When the
vacancy is created in the K, L or M shell, an outer orbital electron will “fall down” to
fill the vacancy, emitting excess energy in the form of electromagnetic radiation
known as characteristic radiation. The radiation is characteristic of the atom of the
target and of the shells between which the transitions took place [16]. The
production of characteristic radiation is illustrated in figure 2-30.
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Figure 2-30 Illustration of the production of characteristic radiation
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2.12 Monte Carlo Simulations
Monte Carlo simulations are computer algorithms that utilise random number
sampling to compute results for complex systems. The Monte Carlo method can be
used to predict dose distributions due to incident photon beams. It is currently the
most promising of the model based dose computation calculations as it uses well
established probability distribution for particle interactions. The dosimetric data for
the TG-43 formalism, used for dosimetry calculations for brachytherapy sources, is
based on a combination of Monte Carlo simulations and thermoluminescent
detector measurements. The current limitation with Monte Carlo simulations is the
long time required to compute the large number of particles necessary to reduce
stochastic uncertainties to acceptable limits [45]. The Monte Carlo method was
coined in the 1940s by John von Neumann, Stanislaw Ulam and Nicholas Metropolis,
while they were working on nuclear weapon projects in the Los Alamos National
Laboratory, LANL, New Mexico, USA. It was named after the famous Monte Carlo
Casino where Ulam’s uncle would gamble as the calculation was based on chance [45].
There are many radiation transport codes available, which are commonly used for
medical physics applications, including;
•

GEANT ( GEometry ANd Tracking) – a high energy physics transport code
from The European Organisation for Nuclear Research (CERN);

•

PENELOPE (PENetration and Energy LOss of Positrons and Electrons) –
electron and photon transport; and
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•

EGS (Electron Gamma Shower) – electron and photon transport from Stanford
Linear Accelerator Centre (SLAC).

Monte Carlo simulations typically involve four key steps;
1. Defining a domain of possible inputs;
2. Generate inputs randomly from the domain using specified probability
distribution;
3. Perform a deterministic computation using the inputs; and
4. Aggregate the results of the individual computations into a final result.
To predict the dose distribution due to incident photon beams within a patient the
steps listed above are described in detail of what they would typically entail below
[46] [47].
During the first step, the user specifies all the information that influences the
desired outcomes of the simulations. This may include but is not limited to;
•

The media which the simulation will take place; this may include tissue,
water, bone in the patient or active volumes of detectors such as silicon.

•

Geometries of the simulation; this may include shapes which represent
structures, phantoms or detectors. Regions that will be used for dosimetric
analysis can be specified as scoring volumes and memory will be set aside for
scoring volumes to hold the required dosimetric data generated from the
simulation. Geometries can heavily affect the speed of the simulation.

•

The dosimetric data to be recorded during the simulation is defined, this may
include; dose deposited, kerma and energy fluence.
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•

The type of radiation to be generated and interactions that the particles may
undergo are also defined. This may include photons, electrons, energy at
which they are generated, direction, primary and secondary interaction they
may partake in such as the photoelectric effect and the amount of particles to
generate.

•

The random number algorithm that will be used must also be defined. The
more complex the algorithm, the more random the sequence is, but the more
time the simulation will take [46] [47].

The second step involves the transportation of the radiation through the virtual
environment. A primary particle is transported through the initial medium, undergoing
interactions as specified in the initial input. The probability of each interaction of the
primary particle is calculated based on the cross-sectional data set. A random
number generator is used to randomly select an interaction from these probabilities
[46] [47].
The path of the primary particle is tracked and the energy lost due to the interaction
is recorded and tabulated. Any secondary particles created from these interactions
are also tracked and each subsequent reaction is tracked until the energy is below a
predetermined cut-off, with the energy loss recorded in the volume if defined as
sensitive. This process is repeated until the predetermined number of particles to
be simulated has been reached [46] [47].
The third step involves the performance of deterministic calculations on the results.
For example, when simulating dosimetric effects of radiation in a medium, the
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deposited dose in each desired sensitive region is calculated as the total energy
deposited within the region divided by the region mass, as specified in the initial step
of the simulation.
The fourth step involves the aggregation of individual results into a final result for
display, matching the format of the desired results specified in the simulation input.
This may include
•

energy spectra in desired regions.

•

dose volume histograms.

•

dosimetric images, such as isodose curves.
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2.13

Geant4

Geant stands for GEometry ANd Tracking, and is a toolkit for the simulation of the
passage of particles through matter.

Geant4 provides basic functionality of

simulations as to describe detector geometry and materials, to transport particles, to
describe detector response and to visualize simulation related information. It also
provides extensive physics models to describe interactions of particles with matter
across a wide range of energies. It was designed and developed under the CERN R&D
project (RD44) from 1994 through to 1998 [48]. It can be used to calculate the results
of radiation models for many different particles with a wide range of energies (250 eV
– Tev). Geant4 simulates many physical particle interactions useful for low energy
photon and electron transport, including:
•

photoelectric effect;

•

Compton scattering;

•

pair-production;

•

Rayleigh scattering;

• bremsstrahlung; and
•

multiple scattering.
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Geant4 utilises user defined classes to create an application which simulates the
interaction of radiation with matter. These user defined classes inherit behaviour
from Geant4 base classes and are used to define elements such as; geometry details,
primary beam details, the physics to consider and how to score energy deposition
in sensitive elements of the geometry. At least three classes must be defined:
•

The detector construction class, which details all of the volumes and
materials used in the simulation;

•

the primary action class, which details the type of incident particle, initial
energy and direction; and

•

the physics list class, which details how these particles and any
secondary particles will interact with the materials of the simulation [49].

The tracking of particles is an important part in the overall performance of the
simulation. To reduce the time of the simulation, the tracking of low energy
particles is usually cut from the simulation when they fall below a threshold. Most
Monte Carlo techniques use a pre-defined energy, which secondary particles are not
tracked if below. Geant4 utilises a different technique for the production thresholds
on secondary particles. If a particle is produced it is tracked until it reaches zero
energy or until it leaves the world volume.
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3. Benchmarking the Model
The Centre for Medical Radiation Physics, University of Wollongong, has recently
developed a real time in vivo dosimetry system that accurately measures the dose
along the urethra during low dose rate prostate brachytherapy. The system is
based on a silicon mini detector directly coupled to a novel miniature amplifier
system within a thin probe. The detector and coupled circuitry require adequate
electromagnetic shielding prior to the initial amplification stage. An encapsulation
featuring a combination of polyamide and aluminium sheets was used to both
provide a hermetically sealed cover as well as electromagnetic shielding, whilst
limiting the probe thickness to allow in vivo insertion through a Foley catheter.
Monte Carlo simulations were performed to optimise the geometry of the device
encapsulation with depth dose response of the detector angular isotropy, and the
effect of depletion region depth the priorities.
As silicon diodes exhibit angular dependence, this must be taken into account if the
angle of the radiation incidence is changed significantly. In permanent low dose rate
brachytherapy, the iodine-125 seeds are implanted into the prostate which surrounds
the urethra and therefore the silicon detector, hence the radiation is incident on the
detector from a large range of directions. Therefore, the angular isotropy of the
detector needs to be investigated, and a lowest possible angular dependence sought.
The depletion layer is a region in a semiconductor material that is free of charge
carriers that have been forcibly removed by an electric field or where they have
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diffused away. The depletion layer is formed across a p-n junction. For materials of
equal concentration of charge carriers, the depletion layer extends equal distances in
in the p and n-type material. If the impurity levels of both materials are different, the
depletion layer will extend further in the material of lowest charge carrier
concentration. The depth of the depletion layer effects the efficient of the detector,
with fully depleted semiconductors more efficient than partially depleted
semiconductor. If the depletion layer that extends the entire thickness of the
semiconductor, the semiconductor is said to be fully depleted. Whilst full depletion is
ideal, it is not always achievable and depends on the bias voltage. Therefore, the
effect of full and partial depletion layers in the detector need to be investigated. [36]
The physics processes that were simulated in the Monte Carlo simulations were:
•

photoelectric effect;

•

Compton scattering;

•

Rayleigh scattering;

•

multiple scattering;

•

ionisation; and

•

bremsstrahlung.

For all physics processes, low energy Livermore packages were used [50] [51].
Secondary particles were tracked with a transport range limit set to 1µm.
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Monte Carlo simulations were performed for one iodine-125 seed, with the dose
deposition within the sensitive volume recorded and displayed in the form of the
average dose deposited per primary particle simulated.
Monte Carlo simulations at full depletion were performed for;

•

A liquid water model;

•

A silicon detector model without aluminium shielding;

•

A silicon detector model with 20 µm of aluminium shielding;

•

A silicon detector model with 50 µm of aluminium shielding; and

•

A silicon detector model with 100 µm of aluminium shielding.

The 20 µm, 50 µm and 100 µm of aluminium shielding were chosen as these were the
available thicknesses that could be incorporated into the manufacturing of the
encapsulation.
The liquid water model was used to benchmark the model to the AAPM’s TG 43
calculations, which are for single brachytherapy seeds within water.
The depth dose response was investigated from 5 – 50 mm from the source in
5 mm increments and the angular isotropy was investigated for 0 – 90° in 15°
increments.
The effect of the depletion layer on the angular isotropy was investigated for the
silicon detector with aluminium shielding for partial depletion layers of 150 µm and
300 µm, compared to the full depletion depth of 350 µm. The partial depletion layer
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depth means the detector is no longer symmetrical in both dimensions through the
cross-section and needs to be investigated for angles 0 – 180° in 15° increments.
A single iodine-125 seed was used as the source for the Monte Carlo simulations and
is illustrated in figure3-1.

Figure 3-1 Diagram of the iodine-125 seed modelled
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3.1 Task Group 43 Calculations
Calculations were performed using the TG 43 protocol and the results were
compared with those from the liquid water model Monte Carlo simulations. The
results from the TG 43 calculations are presented in table 3-1.
Depth (mm)
5
10
15
20
25
30
35
40
45
50

Dose rate (cGy/hr)
4.04
0.960
0.406
0.198
0.115
0.0625
0.0417
0.0313
0.0208
0.0104

Normalised dose rate at 10mm
4.20
1.00
0.406
0.205
0.117
0.0707
0.0465
0.0308
0.0212
0.0146

Table 3-1 Depth dose response from TG-43 calculations for an iodine-125 seed of activity 1U in liquid
water

The reduction in dose rate with depth is due to a combination of an exponential
function due to attenuation, as well as the inverse square law due to spatial effects.
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3.2 Liquid Water Model Simulations
Monte Carlo simulations in liquid water were performed to benchmark the Monte
Carlo model against TG-43 calculations. The results of the Monte Carlo simulations for
the liquid water model are presented in Table 3-2, as a normalised dose at 10 mm and
the percentage difference to TG-43 calculations. It can be seen that there is good
agreement between the results from the Monte Carlo simulation in liquid water and
TG-43 calculations. The average deviation was only 1.7 % ± 4.0% and all results from
the Monte Carlo simulations lie within 6% of the TG-43 calculations. Hence, it can be
concluded that the Monte Carlo simulations applied for the I-125 seed are reliably
calculating the relative dose in liquid water.

Depth (mm)
5
10
15
20
25
30
35
40
45
50

Total dose
(Gy/primary)
2.19E-13
5.36E-14
2.17E-14
1.17E-14
6.67E-15
4.14E-15
2.52E-15
1.69E-15
1.16E-15
8.94E-16

Normalised dose
rate
4.10
1.00
0.405
0.209
0.118
0.0738
0.0473
0.0315
0.0224
0.0150

Percentage
difference with TG43
-2.38
0.00
-0.246
1.95
0.855
4.38
1.72
2.27
5.66
2.74

Table 3-2 Depth dose response from Monte Carlo simulations with a single iodine-125 seed in the
liquid water model, normalised at 10mm
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Figure 3-2 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
TG 43 calculations and Monte Carlo simulations of the liquid water model. Simulation error was less
than 1%.

Angle (degrees)

Total dose (Gy/primary)

0
15
30
45
60
75
90
Average

4.45E-14
4.43E-14
4.44E-14
4.49E-14
4.41E-14
4.44E-14
4.43E-14
4.43E-14

Percentage difference from
average (%)
0.451
0.000
0.226
0.451
-0.451
0.226
0.000

Table 3-3 Angular response from Monte Carlo simulations with a single iodine-125 seed in the liquid
water model at a depth of 10 mm

The angular response of the liquid water model was investigated as a benchmark of
the simulation. Rotations of up to 90 degrees about the model iodine-125 seed were
performed to determine the effect of angular response. For the liquid water model, it
was expected that all results should agree to within ±1%, as this was the maximum
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statistical error of the simulations performed. There should be no angular response
difference for this model, as water does not exhibit angular dependence. Due to
symmetry, the simulations were only performed at angles between 0 and 90 degrees,
in 15 degrees intervals. Therefore, for a 360 degree rotation, the values between 15
and 75 degrees would be incorporated four times; however, the values at 0 and 90
degrees would only be incorporated twice. The average response (R Average ) at varying
angles with samples from 0 to 90 degrees (one quadrant) has therefore been
determined from the individual responses (R i ) using equation 3.1:
R Average = [R 0 + R 90 + [2 x (R 15 + R 30 + R 45 + R 60 +R 75 )]]/12

(3.1)

As shown in figure 3-3, at a depth of 10 mm, the percentage difference with the
average for the liquid water model was found to be within ±0.5%. Therefore the
Monte Carlo liquid water model can be used as a benchmark for future simulations
incorporating the silicon detector model with and without aluminium shielding.
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Figure 3-3 Graphical representation of the percentage difference of the reading to the average
response with angular rotation for the liquid water model. Error represents statistical variations the
simulations to 2 standard deviations.
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4. Silicon Detector Model
The silicon detector model was required to compare the effects of the aluminium
shielding surrounding the silicon detector. In order to do this the silicon detector
model had to be benchmarked against the liquid water model in order to validate the
model.

4.1 Depth dose simulations measured with the
Silicon mini detector
The results for the Monte Carlo simulations for the silicon mini-detector model are
presented in table 4-1, along with the normalised value at 10 mm and the percentage
difference to TG-43 calculations. The agreement for the dose deposited in the Si minidetector is within ±5.5%, however, the maximum discrepancy is observed at the
largest depth from the source where the dose rate is minimal. At distances less than 40
mm, the agreement is within ±2%. The response of the Si mini detector model is
displayed graphically in figure 4-1.
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Depth (mm)
5
10
15
20
25
30
35
40
45
50

Total dose
(Gy/primary)
1.47E-13
3.52E-13
1.45E-13
7.42E-14
4.23E-14
2.57E-14
1.66E-14
1.15E-14
7.56E-15
5.56E-15

Normalised dose
rate
4.16
1.00
0.411
0.210
0.120
0.0731
0.0471
0.0327
0.0215
0.0158

Percentage difference with
liquid water model (%)
1.46
0.000
1.48
0.478
1.69
-0.94
-0.423
3.81
-4.02
5.33

Table 4-1 Depth dose response from Monte Carlo simulations with a single iodine-125 seed in the
silicon detector model

Figure 4-1 Graphical representation of the depth dose response of Si mini detector model for a single
iodine-125 seed placed on a central traversed axis of the detector obtained from Monte Carlo
simulations compared with the liquid water model data. Data was normalised on a depth of 10mm.
Simulation error was less than 1%.

67

4.2 Angular response of the Silicon mini detector
The angular response of the silicon mini-detector model was investigated by rotating
the iodine-125 seed about the detector, as shown in figure 4-2. The seed was virtually
placed at a distance of 10mm from the centre of the silicon detector and orthogonal to
the central axis of the probe. The results were compared to the value of that of the
average response. The results of the Monte Carlo simulations for angular response of
the silicon detector model are presented in table 4-2. It can be seen that the results
are within ±5% of the average response. The greatest effect of angular response was
observed at higher angles. This is due to the increase in material with a higher effective
Z than water (Kapton), which the radiation must penetrate through to reach the
detector as shown in figure 4-2.
Iodine-125 seed

θ

Silicon detector

Kapton

Figure 4-2 Graphical representation of the iodine-125 seed at varying angles about the silicon detector
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Angle (degrees)

Total dose (Gy/primary)

0
15
30
45
60
75
90
Average

2.86E-13
2.86E-13
2.85E-13
2.83E-13
2.78E-13
2.73E-13
2.67E-13
2.80E-13

Percentage difference from
average (%)
2.14
2.14
1.79
1.07
-0.714
-2.50
-4.64

Table 4-2 Angular response from Monte Carlo simulations with a single iodine-125 seed in the silicon
detector model without aluminium shielding

These results are presented graphically in figure 4-3, which clearly show the drop off in
the reading at the greater angles.

Figure 4-3 Graphical representation of the percentage difference of the reading to that of the average
response with angular rotation for the silicon mini-detector without aluminium shielding but
packaged in kapton. The error represents statistical variations in the simulations to 2 standard
deviations.
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5. Silicon Detector with Aluminium

Shielding Models
The aluminium shielding on the detector is required to reduce the effects of the
environmental electromagnetic noise on the signal to noise ratio of the detector
response. However, the aluminium shields also may have some negative effect on the
detector such as attenuating the radiation, increasing the amount of scattered
electrons arriving at the detector and affecting the accuracy of the response with
depth and angular rotation, all of which were investigated. Three thicknesses of
aluminium were investigated; 20 µm, 50 µm and 100 µm. The silicon detector with
aluminium shields modelled into Geant4 is presented in figure 5-1.
1.5 mm

silicon detector

2.5 cm

aluminium shielding

Figure 5-1 Diagram of the silicon detector modelled with aluminium shields
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5.1 Depth dose response of the Silicon mini
detector with aluminium shielding
Monte Carlo simulations were performed for the depth dose response of the silicon
mini detector with 20, 50 and 100 µm of aluminium shielding coupled to the top and
bottom of the probe. The dose deposition was recorded in the silicon detector for an
individual seed at depths from 5 to 50 mm in 5 mm intervals, with the seed at 0°
rotation about the detector face.
1.5 mm
silicon
detector
depth

2.5 cm

iodine-125
seed

aluminium
shielding

Figure 5-2 Schematic diagram of the iodine-125 seed placed at a depth from the mini silicon detector

The results of the Monte Carlo simulations for depth dose response of the mini silicon
detector for 20, 50 and 100 µm are presented in table 5-1, 5-2 and 5-3 respectively and
displayed graphically in figure 5-3. The results for the 20 µm aluminium shielding
model are within ± 2% of the liquid water model for depths up to 35 mm. The results
for the 50 µm aluminium shielding model are within ± 2% of the liquid water model for
depths up to 35 mm. The results for the 100 µm aluminium shielding model are within
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± 2% of the liquid water model for depths up to 40 mm. At depths of 40 mm and
beyond where the dose rate is minimal, there is less than 7% of the dose rate present
at 5 mm for all aluminium thickness shielding models. LDR permanent brachytherapy
implants at St George Cancer Care Centre, Kogarah NSW are restricted to a volume of
60 cc with the average being 40 cc. This roughly equates to a maximum width of 5.5 –
6.0 cm, therefore the accuracy of the mini silicon detector is most critical at distances
between 0 – 30 mm. The TG43 recommendations state the total dose calculation
uncertainties are 6.7%, 5.7%, and 7.3% at 0.1, 1, and 5 cm, respectively. Hence, even
at the maximum depth of 50 mm, the results are within the uncertainties of the TG43
formalism.

Depth
(mm)

Total dose
(Gy/primary)

Normalised
dose rate

5
10
15
20
25
30
35
40
45
50

1.47E-12
3.54E-13
1.44E-13
7.45E-14
4.26E-14
2.60E-14
1.65E-14
1.14E-14
7.62E-15
5.61E-15

4.15
1.00
0.407
0.210
0.120
0.0734
0.0466
0.0322
0.0215
0.0158

Percentage
difference with
liquid water
model (%)
1.22
0.000
0.493
0.478
1.69
-0.542
-1.48
2.22
-4.01
5.33

Percentage difference
with silicon detector
model (%)
-0.240
0.000
-0.973
0.000
0.000
0.410
-1.06
-1.53
0.000
0.000

Table 5-1 Normalised depth dose rate and percentage difference compared with the liquid water and
silicon detector model for the Monte Carlo simulations with a single I-125 seed in the silicon detector
model with 20 micrometers of aluminium shielding
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Depth
(mm)

Total dose
(Gy/primary)

Normalised
dose rate

5
10
15
20
25
30
35
40
45
50

1.45E-12
3.47E-13
1.43E-13
7.28E-14
4.16E-14
2.53E-14
1.63E-14
1.14E-14
7.44E-15
5.45E-15

4.18
1.00
0.412
0.210
0.120
0.0729
0.0470
0.0329
0.0214
0.0157

Percentage
Percentage difference
difference with
with silicon detector
liquid water model
model (%)
(%)
1.95
0.481
0.000
0.000
1.73
0.243
0.478
0.000
1.69
0.000
-1.21
-0.274
-0.634
-0.212
4.44
0.612
-4.46
-0.465
4.67
-0.633

Table 5-2 Normalised depth dose rate and percentage difference compared with the liquid water and
silicon detector model for the Monte Carlo simulations with a single I-125 seed in the silicon detector
model with 50 micrometers of aluminium shielding

Depth
(mm)
5
10
15
20
25
30
35
40
45
50

Total dose Normalised
(Gy/primary) dose rate
1.42E-12
3.40E-13
1.40E-13
7.11E-14
4.05E-14
2.46E-14
1.60E-14
1.09E-14
7.27E-15
5.33E-15

4.18
1.00
0.412
0.209
0.119
0.0724
0.0471
0.0321
0.0214
0.0157

Percentage
difference with
liquid water model
(%)
1.95
0.000
1.73
0.0563
0.947
-1.96
-0.510
1.77
-4.46
4.51

Percentage difference
with silicon detector
model (%)
0.481
0.000
0.488
-0.476
-0.833
-0.822
0.213
-1.53
0.000
-0.633

Table 5-3 Normalised depth dose rate and percentage difference compared with the liquid water and
silicon detector model for the Monte Carlo simulations with a single I-125 seed in the silicon detector
model with 100 micrometers of aluminium shielding
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Figure 5-3 Graphical comparison of depth dose rate response from a single iodine-125 seed obtained
from Monte Carlo simulations of all the silicon detector models with aluminium shielding and the
liquid water model. Simulation error was less than 1% (2 standard deviations).

Figure 5-4 compares the dose deposited at 0 degrees in the silicon detector model to
the dose in the silicon detector with 20, 50 and 100 µm of aluminium shielding. It can
be seen that the aluminium shielding increases the dose deposited. This is due to an
increase in scattered electrons arriving at the detector. As the thickness of aluminium
is increased, however, a reduction in dose deposited within the detector is observed.
For all thicknesses of aluminium shielding, the normalised depth dose distributions are
within 2.0% for depths up to 35mm from the source and within 5.4% up to 50mm from
the source, when compared to the liquid water simulation.
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Relative dose deposited at 0 degrees

Relative Dose

1.4

1.2

1

0.8
0

20

40

60

80

100

Aluminium thickness (um)

Figure 5-4 Relative dose deposited at 0 degrees in the silicon detector model without aluminium
shielding and the silicon detector models with aluminium shielding at 0 degrees and 10 mm depth
(statistical error less than 1%).
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5.2 Angular response of the Silicon mini detector
with aluminium shielding
Monte Carlo simulations were performed for the angular response of the silicon mini
detector with 20, 50 and 100 µm of aluminium shielding coupled to the top and
bottom of the probe. The dose was recorded in the silicon detector for an individual
seed at a depth of 10 mm with the seed rotated at angles 0 to 90 degrees in 15 degree
increments about the probe axis.

Figure 5-5 Schematic diagram of the iodine-125 seed rotating around the silicon detector about the
probe axis

The results of the Monte Carlo simulations for angular response of the mini silicon
detector for 20, 50 and 100 µm are presented in table 5-4, 5-5 and 5-6 respectively,
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and displayed graphically in figure 5-6, where the responses are represented as the
average dose deposited in the detector per simulated primary particle.

Angle (degrees)

Dose rate (Gy/primary)

0
15
30
45
60
75
90
Average

3.54E-13
3.55E-13
3.53E-13
3.49E-13
3.43E-13
3.38E-13
3.33E-13
3.47E-13

Percentage difference from
average (%)
2.02
2.31
1.73
0.576
-1.15
-2.59
-4.03

Table 5-4 Total dose and the percentage difference of the reading to the average response with
angular rotation for the silicon detector with 20 micrometers of aluminium shielding

Angle (degrees)

Dose rate (Gy/primary)

0
15
30
45
60
75
90
Average

3.49E-13
3.49E-13
3.47E-13
3.43E-13
3.35E-13
3.35E-13
3.31E-13
3.42E-13

Percentage difference from
average (%)
2.05
2.05
1.46
0.292
-2.05
-2.05
-3.22

Table 5-5 Total dose and the percentage difference of the reading to the average response with
angular rotation for the silicon detector with 50 micrometers of aluminium shielding
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Angle (degrees)

Dose rate (Gy/primary)

0
15
30
45
60
75
90
Average

3.41E-13
3.42E-13
3.39E-13
3.32E-13
3.23E-13
3.31E-13
3.28E-13
3.34E-13

Percentage difference from
average (%)
2.10
2.40
1.50
-0.599
-3.29
-0.898
-1.80

Table 5-6 Total dose and the percentage difference of the reading to the average response with
angular rotation for the silicon detector with 100 micrometers of aluminium shielding

Figure 5-6 Graphical representation of the percentage difference of the reading to the average
response with angular rotation for all the silicon detector with aluminium shielding models. The error
represents statistical variations in Monte Carlo to 2 standard deviations.
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The percentage difference to the average response of the silicon mini detector with
aluminium shielding was within ±4.03% for all aluminium thicknesses. The maximum
percentage difference from the average angular response was -4.03% for 20µm of
aluminium shielding, -3.22% for 50µm of aluminium shielding and -3.29% for 100µm of
aluminium shielding. The greatest effect of angular response was observed at larger
angles. This is due to the increase in material with higher effective Z than water,
aluminium and kapton, which the radiation must penetrate through to reach the
detector. As demonstrated in figure 5-4, the presence of the aluminium increases the
detector response, however, an increase in aluminium thickness leads to a decrease in
response. The thickness of aluminium in a direct line from the source to the detector
increases with angle as a function of 1/cosθ, however, as the aluminium shields do not
cover the sides of the detector, a maximum reduction in detector response occurs for
the 100µm at 60°, after which it reduces for larger angles up to 90°.
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6. Depletion Depth Consideration
The silicon mini-detectors within the urethral mini-dosimeter probe were designed to
have excellent angular dependence when operated fully depleted. A Monte Carlo study
was performed, for partial depletion depths of 150 µm and 300 µm, with the three
options of aluminium shielding, to determine the effect of using the device with a
sub-optimal depletion region in the detector, which may occur during operation if an
incorrect bias is applied. The response of the detector at these partial depletion
depths was compared to the response of the detector under a full depletion depth of
350 µm. The angular response of the detector was compared to the average response
of the detector. Due to symmetry, the simulations were only performed at angles
between 0 and 180 degrees, in 15 degrees intervals. Therefore, for a 360 degree
rotation, the values between 15 and 165 degrees would be incorporated twice,
however, the values at 0 and 180 degrees would only be incorporated once. The
average response (R Average ) at varying angles with samples from 0 to 180 degrees (two
quadrants) has therefore been determined from the individual responses (R i ) using
equation 6.1:
R Average = [R 0 + R 180 + [2 x (R 15 + R 30 + ….. + R 150 +R 165 )]]/24

(6.1)

The silicon detector with partial depletion regions modelled into GEANT 4 is
presented in figure 6-1 and 6.2.
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1.5 mm

z

silicon detector
Depletion depth of 150 µm
Depletion depth of 300 µm
2.5 cm

aluminium shielding

y

Figure 6-1 Cross sectional view of the silicon detector with partial depletion regions, as well as
aluminium shielding, as modelled in Geant4

z

x

Figure 6-2 Schematic of the mini-silicon detector in the vertical plane, with the lateral depletion in
length and width, as modelled in Geant4

Figure 6-1 shows the extension of the depletion region with depth through the silicon
bulk for the partial depletion depths of 150 µm and 300 µm. As the depletion layer
extends through the bulk with depth, a lateral extension occurs in width (x direction)
and length (z direction), as shown in figure 6-2. The Geant4 model was adjusted to
provide a sensitive region representing the depletion depths of 150 µm and 300 µm.
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The lateral extension of the depletion layer was modelled to extend in the x and z
directions in proportion to the fraction of the depletion depth relative to the bulk
thickness (350 µm), such that the device is fully depleted laterally when the depletion
depth reaches the end of the bulk. For the 150 µm partial depletion depth, the
depletion was calculated to extend 243 µm in width (x direction) and 1.36 mm in
length (z direction), relative to the centre of the detector. The 300 µm partial
depletion depth extended 361 µm in width (x direction) and 1.46 mm in length (z
direction).
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6.1 150 µm depletion region for the 20 µm of
aluminium shielding model
The results for the Monte Carlo simulations for the silicon detector with 20 µm of
aluminium shielding and a 150 µm depth depletion region are presented in table 6-1,
along with the percentage difference from the average. It can be seen that the
maximum percentage difference is 9.47% from the average dose.

Angle (degrees)

Dose rate (Gy/primary)

0
15
30
45
60
75
90
105
120
135
150
165
180
Average

3.70E-13
3.68E-13
3.67E-13
3.61E-13
3.52E-13
3.42E-13
3.26E-13
3.17E-13
3.13E-13
3.17E-13
3.23E-13
3.23E-13
3.27E-13
3.38E-13

Percentage difference
from average (%)
9.47
8.88
8.58
6.80
4.14
1.18
-3.55
-6.21
-7.40
-6.21
-4.44
-4.44
-3.25

Table 6-1 Dose rate and the percentage difference of the average dose with angular rotation for the
silicon detector with 20 micrometers of aluminium shielding and a partial depletion layer of 150
micrometers
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Figure 6-3 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
Monte Carlo simulations of the silicon detector model with 20 micrometers of aluminium shielding
and a partial depletion layer of 150 micrometers
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6.2 150 µm depletion region for the 50 µm of
aluminium shielding model
The results for the Monte Carlo simulations for the silicon detector with 50 µm of
aluminium shielding and a 150 µm depth depletion region are presented in table 6-2,
along with the percentage difference from the average. It can be seen that the
maximum percentage difference is 9.01 % from the average dose.

Angle (degrees)

Dose rate (Gy/primary)

Percentage difference from
average (%)

0
15
30
45
60
75
90
105
120
135
150
165
180
Average

3.63E-13
3.62E-13
3.57E-13
3.53E-13
3.44E-13
3.38E-13
3.23E-13
3.14E-13
3.09E-13
3.13E-13
3.18E-13
3.21E-13
3.22E-13

9.01
8.71
7.21
6.01
3.30
1.50
-3.00
-5.71
-7.21
-6.01
-4.50
-3.60
-3.30

3.33E-13

Table 6-2 Total dose and the percentage difference of the average dose with angular rotation for the
silicon detector with 50 micrometers of aluminium shielding and a partial depletion layer of 150
micrometers
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Figure 6-4 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
Monte Carlo simulations of the silicon detector model with 50 micrometers of aluminium shielding
and a partial depletion layer of 150 micrometers
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6.3 150 µm depletion region for the 100 µm of
aluminium shielding model
The results for the Monte Carlo simulations for the silicon detector with 100 µm of
aluminium shielding and a 150 µm depth depletion region are presented in table 6-3,
along with the percentage difference from the average. It can be seen that the
maximum percentage difference is 8.92% from the average dose.

Angle (degrees)

Dose rate (Gy/primary)

0
15
30
45
60
75
90
105
120
135
150
165
180
Average

3.54E-13
3.53E-13
3.50E-13
3.43E-13
3.32E-13
3.33E-13
3.19E-13
3.13E-13
2.97E-13
3.02E-13
3.12E-13
3.16E-13
3.14E-13
3.251E-13

Percentage difference from
average (%)
8.92
8.62
7.69
5.54
2.15
2.46
-1.85
-3.69
-8.62
-7.08
-4.00
-2.77
-3.38

Table 6.3 Total dose and the percentage difference of the average dose with angular rotation for the
silicon detector with 100 micrometers of aluminium shielding and a partial depletion layer of 150
micrometers
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Figure 6-5 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
Monte Carlo simulations of the silicon detector model with 100 micrometers of aluminium shielding
and a partial depletion layer of 150 micrometers
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6.4 300 µm depletion region for the 20 µm of
aluminium shielding model
The results for the Monte Carlo simulations for the silicon detector with 20 µm of
aluminium shielding and a 300 µm depth depletion region are presented in table 6-4,
along with the percentage difference from the average. It can be seen that the
maximum percentage difference is -7.04% from the average dose.

Angle (degrees)

Dose rate (Gy/primary)

Percentage difference
from average (%)

0
15
30
45
60
75
90
105
120
135
150
165
180
Average

3.57E-13
3.57E-13
3.54E-13
3.32E-13
3.32E-13
3.39E-13
3.32E-13
3.17E-13
3.35E-13
3.42E-13
3.47E-13
3.47E-13
3.47E-13

4.69
4.69
3.81
-2.64
-2.64
-0.59
-2.64
-7.04
-1.76
0.29
1.76
1.76
1.76

3.41E-13

Table 6-4 Total dose and the percentage difference of the average dose angular rotation for the
silicon detector with 20 micrometers of aluminium shielding and a partial depletion layer of 300
micrometers
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Figure 6-6 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
Monte Carlo simulations of the silicon detector model with 20 micrometers of aluminium shielding
and a partial depletion layer of 300 micrometers
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6.5 300 µm depletion region for the 50 µm of
aluminium shielding model
The results for the Monte Carlo simulations for the silicon detector with 50 µm of
aluminium shielding and a 300 µm depth depletion region are presented in table 6-5,
along with the percentage difference from the average. It can be seen that the
maximum percentage difference is 3.83% from the average dose.

Angle (degrees)

Dose rate (Gy/primary)

Percentage difference from
average (%)

0
15
30
45
60
75
90
105
120
135
150
165
180
Average

3.52E-13
3.51E-13
3.49E-13
3.45E-13
3.36E-13
3.37E-13
3.29E-13
3.29E-13
3.28E-13
3.36E-13
3.40E-13
3.42E-13
3.42E-13

3.83
3.54
2.95
1.77
-0.88
-0.59
-2.95
-2.95
-3.24
-0.88
0.29
0.88
0.88

3.39E-13

Table 6-5 Total dose and the percentage difference of the average dose with angular rotation for the
silicon detector with 50 micrometers of aluminium shielding and a partial depletion layer of 300
micrometers
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Figure 6-7 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
Monte Carlo simulations of the silicon detector model with 50 micrometers of aluminium shielding
and a partial depletion layer of 300 micrometers
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6.6 300 µm depletion region for the 100 µm of
aluminium shielding model
The results for the Monte Carlo simulations for the silicon detector with 100 µm of
aluminium shielding and a 300 µm depth depletion region are presented in table 6-6,
along with the percentage difference from the average. It can be seen that the
maximum percentage difference is -4.23 % from the average dose.

Angle (degrees)

Dose rate(Gy/primary )

Percentage difference from
average (%)

0
15
30
45
60
75
90
105
120
135
150
165
180
Average

3.43E-13
3.44E-13
3.41E-13
3.35E-13
3.24E-13
3.32E-13
3.26E-13
3.25E-13
3.17E-13
3.25E-13
3.32E-13
3.35E-13
3.34E-13

3.63
3.93
3.02
1.21
-2.11
0.30
-1.51
-1.81
-4.23
-1.81
0.30
1.21
0.91

3.31E-13

Table 6-6 Total dose and the percentage difference of the average dose with angular rotation for the
silicon detector with 100 micrometers of aluminium shielding and a partial depletion layer of 300
micrometers
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Figure 6-8 Graphical comparison of depth dose response from a single iodine-125 seed obtained from
Monte Carlo simulations of the silicon detector model with 100 micrometers of aluminium shielding
and a partial depletion layer of 300 micrometers

The depletion depth significantly affects the performance of the mini silicon detector,
as expected, with variations of up to ±9.43% for the 150 µm partial depletion layer
depth. The difference is substantially better for the 300 µm partial depletion layer
depth with all results within ±5%, with the exception of one outlier at -7.04% for the
20 µm of aluminium shielding at 105 degrees. There is an unfavourable effect of a
partial depletion on the detector. This is due to the geometry of the detector and
process of depleting the device, as when there is a partial depletion depth, the
sensitive volume forms from only one side of the detector which adversely affects the
sensitivity of the detector. This is evident in the sinusoidal nature of the results above
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as the iodine-125 seed rotates about the detector; a large difference between the
readings at 0 degrees and 180 degrees is observed, due to increased amount of the
un-depleted silicon detector the radiation must penetrate in order to reach the
sensitive volume to be collected. For the detector not being fully depleted, as well as a
lack of a depletion region on the underside of the detector, there is a lack of a
sensitive region on the sides of the device. This also leads to a decrease in response to
radiation from the sides, at 90 degrees. As the introduction of aluminium shields were
found to induce an angular dependence with a decrease in response for angles greater
than 60 degrees when applied to a fully depleted detector, when applied to a device
with a sub-optimal depletion layer, the decrease in response with angle is a
combination of the geometrical effects of the depletion layer and the angular effects
induced by the aluminium shields. This has led to a maximum decrease in response at
angles between 60 to 120 degrees. The efficiency of the mini silicon detector is
severely affected by partial depletion depth, hence, operation at a bias above the
minimum required for full depletion is a necessity.
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7. Discussion
To validate the Monte Carlo models used in the study of the effect of encapsulation
on the urethral mini dosimeter, the depth dose response of the liquid water model
was compared with TG-43 calculations, which are calculated in liquid water. The
liquid water model showed a good agreement (within 6%) with the TG-43 model,
which itself has uncertainties of up to 7.3% within the distances studied.
The depth dose response of the silicon detector model without aluminium shielding
was then benchmarked against the liquid water model. The normalised response of
the silicon detector without aluminium shielding was found to be in good
agreement with the liquid water model, predicting the dose rate to within 1.7% for
depths up to 35mm, and to within 5.4% for depths up to 50mm from the
brachytherapy source .
The depth dose response of the silicon detector model with different thicknesses
of aluminium shielding was benchmarked against the silicon detector model
without aluminium shielding and the liquid water model. All of the silicon detector
models with aluminium shielding were found to be in good agreement with the
silicon detector model without aluminium shielding and the liquid water model.
The angular response of the liquid water model was found to be isotropic, within
the statistical error of the Monte Carlo simulations. The liquid water model was used
to validate the accuracy of the code.
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The angular response of the silicon detector model without aluminium shielding
was found to be within 5% of that of the average response. The angular response of
the silicon detector model was used to investigate the effects of the aluminium
shielding on the detector.
The angular response of the silicon detector model with 20 micrometers of
aluminium shielding was found to be within ±4.1% of the average response. There
was an observed dose enhancement associated with the aluminium shielding; this is
due to an increase in scattered electrons from the aluminium shields arriving at
the detector.
The angular response of the silicon detector model with 50 micrometers of
aluminium shielding was found to be within ±3.3% of the average response. The
observed dose enhancement associated with the aluminium shielding has further
increased due to the thicker aluminium shields.
The angular response of the silicon detector model with 100 micrometers of
aluminium shielding was found to be within ±3.3% of the average response. The
observed dose enhancement associated with the aluminium shielding has again
increased from the no aluminium model due the thicker aluminium shields, resulting
in the lowest overall discrepancy between the lower and higher angles. There was no
reduction in dose due to the increased shielding to that of the 20 or 50 micrometer
model.
The partial depletion layer was found to unfavourably affect the response of the
detector. The effect of the depletion layer depth was found to be most significant at
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the 150 µm depth with the results varying by up to 9.47% from the average. The
results for the 300 µm depletion depth were substantially better with the all of
results within ±5% except for the 20µm aluminium shielding model at 105 degrees
which was -7.04% from the average. Therefore, the efficiency of the detector is
affected by the depth of the depletion layer, with the efficiency decreasing at
shallower depths.
The errors are calculated as 2 sigma (two standard deviations) using statistical
analysis. For every event, the amount of energy deposited is recorded and summed,
as well as the square of the energy deposited. The standard deviation of the result is
then equal to the square root of the average energy squared minus the square of the
average energy, all divided by the number of events.
The TG43 protocol states that the total dose calculation uncertainties are 6.7%, 5.7%,
and 7.3% at 0.1, 1, and 5 cm, respectively. The results within this study are generally
within the range of the uncertainties published in TG-43 [34].
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8. Conclusion
The Geant4 toolkit was successfully used to model the dosimetry system. The
urethral dosimetry system mini detector probe was modelled in a liquid water
phantom and the results compared with the TG43 model. The results were within
6% of the TG43 model, which is within the statistical error of the Monte Carlo
simulations and TG43 data.
The depth dose response of the detector was compared to the equivalent dose in
water and was found to be within ±2%, up to 35mm from the I-125 based
brachytherapy seed, and within 5.4%, up to 50mm from the seed. This is within the
statistical error of the Monte Carlo simulations and TG43 formalism data
uncertainties.
The anisotropy of the Si mini dosimetry detector was investigated. The response of
the detector at varying angles was compared to the average response of the
detector. The results were also found to be within ±5% of the average response,
The effect of the aluminium shielding on the depth dose response and anisotropy
of the detector was investigated. The effect of the aluminium shielding was generally
found to increase with the depth, or distance from the source, relative to the
normalisation point of 1cm. There was no consistency of the percentage difference to
the response at 10 mm and was therefore deemed to be due to the statistical
error of the Monte Carlo simulations. The anisotropy of the detector with the
aluminium shielding was found to have the greatest effect with increasing angles.
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The percentage difference to the average response was deemed to be within
statistical error for the Monte Carlo simulations.
The depth of the depletion layer was found to unfavourably affect the efficiency of
the detector, with the greatest effect at the shallower depth of 150 µm. It is therefore
recommended that the detector to be operated at full depletion.
The effect of the aluminium shielding has been found not to significantly affect the
depth dose or anisotropy response of the detector and should be used to shield
the detector from electromagnetic radiation. The detector should be operated under
full depletion to increase the efficiency of the detector.
The mini-urethral dosimetry system is now able to be constructed with the chosen
thickness of aluminium shielding of 100 µm and implemented in clinical use to
measure the dose in the urethra during low dose rate prostate brachytherapy with
iodine-125 seeds.
Further research on this project includes:
•

construction of the mini-silicon detector with aluminium encapsulation

•

in phantom testing of the shielded mini-silicon detector

•

implementation into clinical use through clinical trails

•

commercialisation of the mini-silicon dosimetry system
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